Mads Jorgen Nohr Clausen
Président chez Clausen Controls Holding Ii ApS
Postes actifs de Mads Jorgen Nohr Clausen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MC2 Therapeutics Ltd.
 MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Directeur/Membre du Conseil | 25/06/2008 | - |
Clausen Controls Holding Ii ApS
 Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Président | 04/05/2022 | - |
Historique de carrière de Mads Jorgen Nohr Clausen
Statistiques
Internationale
| Royaume-Uni | 2 |
| Danemark | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MC2 Therapeutics Ltd.
MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Health Technology |
Clausen Controls Holding Ii ApS
Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Finance |
- Bourse
- Insiders
- Mads Jorgen Nohr Clausen
- Expérience
